These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9751256)
1. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck. Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J Cancer Lett; 1998 Aug; 130(1-2):49-56. PubMed ID: 9751256 [TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients. Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J Eur J Cancer; 1998 Jul; 34(8):1193-7. PubMed ID: 9849478 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984 [TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck. Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J Anticancer Res; 2000; 20(5C):3975-81. PubMed ID: 11268487 [TBL] [Abstract][Full Text] [Related]
5. Cathepsin D and PAI-1 expression in human head and neck cancer. Zeillinger R; Eder S; Schneeberger C; Ullrich R; Speiser P; Swoboda H Anticancer Res; 1996; 16(1):449-53. PubMed ID: 8615652 [TBL] [Abstract][Full Text] [Related]
6. Cathepsin D expression in early cutaneous malignant melanoma. Bartenjev I; Rudolf Z; Stabuc B; Vrhovec I; Perkovic T; Kansky A Int J Dermatol; 2000 Aug; 39(8):599-602. PubMed ID: 10971728 [TBL] [Abstract][Full Text] [Related]
7. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors. Kawasaki G; Kato Y; Mizuno A Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284 [TBL] [Abstract][Full Text] [Related]
8. Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: clinical implications. Leto G; Tumminello FM; Gebbia N; Bazan V; Tomasino RM; Dardanoni G; Russo A Int J Biol Markers; 2001; 16(4):245-9. PubMed ID: 11820719 [TBL] [Abstract][Full Text] [Related]
9. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. Kos J; Smid A; Krasovec M; Svetic B; Lenarcic B; Vrhovec I; Skrk J; Turk V Biol Chem Hoppe Seyler; 1995 Jul; 376(7):401-5. PubMed ID: 7576236 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx. Marsigliante S; Biscozzo L; Resta L; Leo G; Mottaghi A; Maiorano E; Colucci G; Storelli C Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):51-5. PubMed ID: 9135974 [TBL] [Abstract][Full Text] [Related]
11. [Cytosolic cathepsin D levels in squamous carcinomas of the lung]. Ruibal A; Núñez MI; Río Mdel C; García Díez S; Rodríguez J; Alvarez de Linera JF Med Clin (Barc); 2003 Feb; 120(3):81-4. PubMed ID: 12605727 [TBL] [Abstract][Full Text] [Related]
12. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372 [TBL] [Abstract][Full Text] [Related]
13. Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters. Maudelonde T; Khalaf S; Garcia M; Freiss G; Duporte J; Benatia M; Rogier H; Paolucci F; Simony J; Pujol H Cancer Res; 1988 Jan; 48(2):462-6. PubMed ID: 3275497 [TBL] [Abstract][Full Text] [Related]
14. Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma. Nazeer T; Malfetano JH; Rosano TG; Ross JS Am J Clin Pathol; 1992 Jun; 97(6):764-9. PubMed ID: 1595596 [TBL] [Abstract][Full Text] [Related]
15. Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck. Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Skrk J Neoplasma; 2001; 48(1):66-71. PubMed ID: 11327540 [TBL] [Abstract][Full Text] [Related]
16. Expression of cathepsin D in head and neck cancer. Zeillinger R; Swoboda H; Machacek E; Nekahm D; Sliutz G; Knogler W; Speiser P; Swoboda E; Kubista E Eur J Cancer; 1992; 28A(8-9):1413-5. PubMed ID: 1515261 [TBL] [Abstract][Full Text] [Related]
17. Serum cystatin C in patients with head and neck carcinoma. Strojan P; Svetic B; Smid L; Kos J Clin Chim Acta; 2004 Jun; 344(1-2):155-61. PubMed ID: 15149884 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma. Riedel F; Götte K; Schwalb J; Hörmann K Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721 [TBL] [Abstract][Full Text] [Related]
19. Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma. Li G; Da M; Zhang W; Wu H; Ye J; Chen J; Ma L; Gu N; Wu Y; Song X J Oral Pathol Med; 2016 Mar; 45(3):167-72. PubMed ID: 26189546 [TBL] [Abstract][Full Text] [Related]
20. Protein kinase activities in neoplastic squamous epithelia and normal epithelia from the upper aero-digestive tract. Rydell EL; Axelsson KL; Olofsson J; Hellem S Cancer Biochem Biophys; 1990 Jul; 11(3):187-94. PubMed ID: 2268849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]